Short-chain fatty acid production enhancement

"Short-chain fatty acid production enhancement" is not the name of a specific molecule, receptor, enzyme, or other canonical therapeutic target. Instead, it refers to the **process** by which gut microbiota ferment dietary fibers and resistant starches in the colon to produce short-chain fatty acids (SCFAs), primarily acetate, propionate, and butyrate[1][3][4]. These SCFAs are absorbed by colonocytes via monocarboxylate transporters and can act on various G protein-coupled receptors such as free fatty acid receptor 2 (FFAR2), free fatty acid receptor 3 (FFAR3), GPR109A/HCAR2, and others. SCFAs play important roles in maintaining intestinal barrier integrity, modulating immune responses—including protection against inflammation—and influencing systemic metabolism and even brain function through gut-brain communication pathways[1][3][4]. Because "short-chain fatty acid production enhancement" describes an outcome or intervention goal rather than a discrete molecular entity or druggable target classically defined in pharmacology or molecular biology—such as "free fatty acid receptor 2"—it is not considered a valid therapeutic target itself. Instead, research often focuses on modulating microbial populations or their metabolic activity to increase endogenous SCFA levels for health benefits. If you are seeking structured information about actual targets involved in this pathway—such as FFAR2/FFAR3 receptors or monocarboxylate transporters—please specify those molecules directly for accurate data extraction. In summary: > "Short-chain fatty acid production enhancement" is not itself a canonical molecular target but refers broadly to increasing the output of beneficial metabolites from gut microbiota fermentation processes. It does not correspond to any single gene product/protein/receptor/enzyme that can be targeted by drugs; thus it should be flagged as an incorrect entry for structured drug-target databases.[1][3]

Other names

Short-chain fatty acid productionSCFA production enhancementEnhancement of short-chain fatty acid synthesis